These are exceedingly rare and characterized by the presence of defining molecular alterations of both astrocytoma (ATRX loss/mutation and TP53 mutation) and oligodendroglioma (whole-arm 1p/19q codeletion). Here, TP53 is linked to astrocytoma (excluding glioblastoma).